ATE405555T1 - Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält - Google Patents
Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthältInfo
- Publication number
- ATE405555T1 ATE405555T1 AT02700580T AT02700580T ATE405555T1 AT E405555 T1 ATE405555 T1 AT E405555T1 AT 02700580 T AT02700580 T AT 02700580T AT 02700580 T AT02700580 T AT 02700580T AT E405555 T1 ATE405555 T1 AT E405555T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- medical composition
- thiazine derivative
- optionally substituted
- thiazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001065386 | 2001-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE405555T1 true ATE405555T1 (de) | 2008-09-15 |
Family
ID=18924048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700580T ATE405555T1 (de) | 2001-03-08 | 2002-02-14 | Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält |
Country Status (11)
Country | Link |
---|---|
US (1) | US6916806B2 (de) |
EP (1) | EP1375489B1 (de) |
JP (1) | JP4188694B2 (de) |
KR (2) | KR100642570B1 (de) |
CN (1) | CN1301981C (de) |
AT (1) | ATE405555T1 (de) |
BR (1) | BR0207966A (de) |
CA (1) | CA2440186C (de) |
DE (1) | DE60228429D1 (de) |
MX (1) | MXPA03008033A (de) |
WO (1) | WO2002072562A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3936189B2 (ja) * | 1999-09-14 | 2007-06-27 | 塩野義製薬株式会社 | 2−イミノ−1,3−チアジン誘導体 |
JPWO2003070277A1 (ja) * | 2002-02-19 | 2005-06-09 | 塩野義製薬株式会社 | 抗掻痒剤 |
US20070027144A1 (en) * | 2003-08-18 | 2007-02-01 | Shionogi & Co., Ltd. | Novel use of cannabinoid receptor agonist |
TW200508211A (en) * | 2003-08-26 | 2005-03-01 | Shionogi & Co | 2-naphthylimino-1,3-thiazine derivatives |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
WO2006080284A1 (ja) * | 2005-01-25 | 2006-08-03 | Shionogi & Co., Ltd. | 2-置換イミノ-1,3-オキサジン誘導体 |
WO2006080287A1 (ja) * | 2005-01-25 | 2006-08-03 | Shionogi & Co., Ltd. | 2-アゾリルイミノ-1,3-チアジン誘導体 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6165894A (ja) | 1984-09-08 | 1986-04-04 | Shionogi & Co Ltd | チアジンホスホン酸誘導体とその製法および殺虫剤 |
JPS6229594A (ja) | 1985-07-31 | 1987-02-07 | Shionogi & Co Ltd | チアジン環を有する有機燐化合物 |
JPS62120374A (ja) * | 1985-11-20 | 1987-06-01 | Yoshitomi Pharmaceut Ind Ltd | 1,3−チアジンまたは1,3−オキサジン誘導体 |
NL8702437A (nl) * | 1987-10-13 | 1989-05-01 | Geo Kinetics B V I O | Werkwijze voor het conditioneren van grondmateriaal door elektrokinetische behandeling, elektrisch stroomsysteem voor toepassing van de werkwijze alsmede elektrode-behuizing voor toepassing in het elektrische stroomsysteem. |
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
US5194434A (en) * | 1991-12-03 | 1993-03-16 | Texas A&M University System | Use of OB-101 to treat ocular inflammation |
CA2245586A1 (en) * | 1996-02-06 | 1997-08-14 | Japan Tobacco Inc. | Novel compounds and pharmaceutical use thereof |
CA2283797A1 (en) | 1997-03-18 | 1998-09-24 | Paul Elliot Bender | Novel cannabinoid receptor agonists |
KR20010021696A (ko) | 1997-07-11 | 2001-03-15 | 미즈노 마사루 | 퀴놀린 화합물 및 그의 의약용도 |
DE19837627A1 (de) * | 1998-08-19 | 2000-02-24 | Bayer Ag | Neue Aminosäureester von Arylsulfonamiden und Analoga |
EP1144396A2 (de) * | 1999-01-14 | 2001-10-17 | Bayer Corporation | Substituierte 2-arylamino-heterocyclen und diese enthaltende zusammensetzungen zur verwendung als mittel, die den progesteron-rezeptor binden |
JP3936189B2 (ja) | 1999-09-14 | 2007-06-27 | 塩野義製薬株式会社 | 2−イミノ−1,3−チアジン誘導体 |
-
2002
- 2002-02-14 JP JP2002571478A patent/JP4188694B2/ja not_active Expired - Fee Related
- 2002-02-14 US US10/470,388 patent/US6916806B2/en not_active Expired - Fee Related
- 2002-02-14 BR BR0207966-6A patent/BR0207966A/pt not_active IP Right Cessation
- 2002-02-14 CN CNB028062108A patent/CN1301981C/zh not_active Expired - Fee Related
- 2002-02-14 DE DE60228429T patent/DE60228429D1/de not_active Expired - Lifetime
- 2002-02-14 EP EP02700580A patent/EP1375489B1/de not_active Expired - Lifetime
- 2002-02-14 AT AT02700580T patent/ATE405555T1/de not_active IP Right Cessation
- 2002-02-14 MX MXPA03008033A patent/MXPA03008033A/es active IP Right Grant
- 2002-02-14 KR KR1020037011711A patent/KR100642570B1/ko not_active IP Right Cessation
- 2002-02-14 KR KR1020067005884A patent/KR20060029296A/ko not_active Application Discontinuation
- 2002-02-14 CA CA002440186A patent/CA2440186C/en not_active Expired - Fee Related
- 2002-02-14 WO PCT/JP2002/001229 patent/WO2002072562A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR100642570B1 (ko) | 2006-11-10 |
EP1375489A4 (de) | 2005-03-02 |
KR20060029296A (ko) | 2006-04-05 |
CA2440186A1 (en) | 2002-09-19 |
US20040116326A1 (en) | 2004-06-17 |
EP1375489A1 (de) | 2004-01-02 |
JP4188694B2 (ja) | 2008-11-26 |
CA2440186C (en) | 2009-01-13 |
DE60228429D1 (de) | 2008-10-02 |
CN1301981C (zh) | 2007-02-28 |
JPWO2002072562A1 (ja) | 2004-07-02 |
BR0207966A (pt) | 2004-06-15 |
MXPA03008033A (es) | 2003-12-04 |
WO2002072562A1 (fr) | 2002-09-19 |
CN1514831A (zh) | 2004-07-21 |
EP1375489B1 (de) | 2008-08-20 |
US6916806B2 (en) | 2005-07-12 |
KR20040007462A (ko) | 2004-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1046639A1 (en) | Nitroimidazole external preparations for dermatosis | |
NO953305L (no) | Antranilsyrederivat | |
DE60038687D1 (de) | 2-imino-1,3-thiazin-derivate | |
DE69929669D1 (de) | Zyklische Amidderivate die Cathepsin K hemmen | |
ATE190052T1 (de) | Thiazolidindione-derivate, ihre herstellung und verwendung | |
PT807630E (pt) | Compostos heterociclicos | |
DK0791007T3 (da) | Antifungale sordaridinderivater | |
ATE289810T1 (de) | Ecteinascidinderivate | |
PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
ATE122344T1 (de) | Naphthyloxazolidon-derivate. | |
DE69937045D1 (de) | Cyclische amidderivate | |
ATE405555T1 (de) | Medizinische zusammensetzung, die ein 1,3- thiazinderivat enthält | |
DK1031556T3 (da) | 2-phenoxyanilinderivater | |
MXPA03008250A (es) | Nuevos derivados de diaminopirazol y colorantes que contienen estos compuestos. | |
DK1559714T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater | |
TR200200347T2 (tr) | 1,4-İkameli 4,4-diaril sikloheksanlar. | |
EP1211253A4 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
DE69906243D1 (de) | 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe | |
CA2297112A1 (en) | Dicyclanil polymorphs and hydrates and their preparation | |
ATE340175T1 (de) | Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase | |
EP1148059A4 (de) | Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
DE59905342D1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
TH26544A (th) | อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |